Among patients who had undergone curative surgery for primary colorectal cancer, the screening methods of computed tomography and carcinoembryonic antigen each provided an improved rate of surgical ...

Molecular recurrence signals preceded symptoms or imaging in all recurrences observed, indicating ctDNA may enable earlier ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

The researchers found that after 3 years of follow-up, time to recurrence was lower for participants assigned to aspirin versus placebo. A similar trend was seen for disease-free survival hazard ...

SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) recurrence, according to a randomized study reported here.

The National Cancer Institute predicts that colorectal cancers will make up 8% of new cancer cases in 2025, and it is often recurring, so scientists are looking for ways to reduce the risk of it ...

A new study suggests a medicine cabinet mainstay could be helpful in reducing the risk of colorectal cancer coming back. A small dose of aspirin was shown to halve recurrences of colorectal cancer in ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

Add Yahoo as a preferred source to see more of our stories on Google. (NewsNation) — A new study suggests a medicine cabinet mainstay could be helpful in reducing the risk of colorectal cancer coming ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors returning after surgery. This readily available and inexpensive treatment ...